These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32840470)

  • 1. Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer.
    Kim M; Suh CH; Lee SM; Kim HC; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    Radiology; 2020 Nov; 297(2):419-427. PubMed ID: 32840470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis.
    Kim M; Suh CH; Lee SM; Park JE; Kim HC; Kim SO; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    AJR Am J Roentgenol; 2021 Nov; 217(5):1184-1193. PubMed ID: 34037408
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
    Park S; Lee SM; Ahn Y; Kim M; Suh CH; Do KH; Seo JB
    Eur Radiol; 2022 Feb; 32(2):990-1001. PubMed ID: 34378076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
    Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
    Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI.
    Tang W; Wu N; OuYang H; Huang Y; Liu L; Li M
    Cancer Imaging; 2015 Sep; 15(1):14. PubMed ID: 26335333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
    Park J; Kobayashi Y; Urayama KY; Yamaura H; Yatabe Y; Hida T
    PLoS One; 2016; 11(8):e0161081. PubMed ID: 27518729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
    Rice SR; Molitoris JK; Vyfhuis MAL; Edelman MJ; Burrows WM; Feliciano J; Nichols EM; Suntharalingam M; Donahue J; Carr SR; Friedberg J; Badiyan S; Simone CB; Feigenberg SJ; Mohindra P
    Clin Lung Cancer; 2019 Jan; 20(1):e107-e114. PubMed ID: 30337268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
    Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL
    Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
    Taylor SA; Mallett S; Ball S; Beare S; Bhatnagar G; Bhowmik A; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Lock S; Miles A; Morris S; Morton A; Navani N; Oliver A; O'Shaughnessy T; Padhani AR; Prezzi D; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Russell P; Sidhu HS; Strickland N; Tarver K; Teague J; Halligan S;
    Lancet Respir Med; 2019 Jun; 7(6):523-532. PubMed ID: 31080129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor.
    Weber B; Winterdahl M; Memon A; Sorensen BS; Keiding S; Sorensen L; Nexo E; Meldgaard P
    J Thorac Oncol; 2011 Jul; 6(7):1287-9. PubMed ID: 21847041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy.
    Aaby C; Kristensen S; Nielsen SM
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):279-85. PubMed ID: 8587782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
    Balekian AA; Fisher JM; Gould MK
    Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
    Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
    Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.
    Liang H; Song X; Zhang Y; Zhang S; Li F; Fang J; Li J; Liang L; Nie L; Ma K; Zhang L; Wang X; Xu J; Wei Y; Wang J; Song Q; Tian G; Mu Y; Gu Y; Yang L; Sun P; Zhong W; Zhao J; Xu Y; Chen M; Wang M
    Thorac Cancer; 2019 Jul; 10(7):1521-1532. PubMed ID: 31144459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer histologies associated with emphysema on computed tomography.
    Smith BM; Schwartzman K; Kovacina B; Taylor J; Kasymjanova G; Brandao G; Agulnik JS
    Lung Cancer; 2012 Apr; 76(1):61-6. PubMed ID: 21945657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
    Shi AA; Digumarthy SR; Temel JS; Halpern EF; Kuester LB; Aquino SL
    J Thorac Oncol; 2006 Mar; 1(3):205-10. PubMed ID: 17409858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of computed tomography morphologic characteristics in stage I non-small-cell lung cancer.
    Meniga IN; Tiljak MK; Ivankovic D; Aleric I; Zekan M; Hrabac P; Mazuranic I; Puljic I
    Clin Lung Cancer; 2010 Mar; 11(2):98-104. PubMed ID: 20199975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.